.png){kind=logo} | |
 Headquarters in Shenzhen | |
| Company type | Public |
|---|---|
| SZSE:300760 CSI A50 | |
| Industry | Healthcare |
| Founded | 1991; 34 years ago (1991) Shenzhen |
| Headquarters | Mindray Building,, |
Area served | Worldwide |
Key people | Li Xiting (chairman) Xu Hang (co-founder) Cheng Minghe (executive VP) Wu Hao (CEO) |
| Products | |
| Revenue |  US$5.1 Billion (2024) |
| US$1.54 Billion (2024) | |
| US$1.46 Billion (2024) | |
Number of employees | 21,000 (2025)[1] |
| Website | mindray.com |
| Footnotes / references [2] | |
Mindray Bio-Medical Electronics Co., Ltd. (simplified Chinese:迈瑞生物医疗电子股份有限公司;traditional Chinese:邁瑞生物醫療電子股份有限公司;pinyin:Mài Ruì Shēng Wù Yī Liáo Diàn Zǐ Gǔ Fèn Yǒu Xiàn Gōng Sī) is a Chinese multinationalhealth technology company based inShenzhen,Guangdong. Mindray designs and produces medical equipment and accessories for bothhuman andveterinary use. The company is organized into three key business lines: Patient Monitoring &Life Support,In-Vitro Diagnostic Products, andMedical Imaging Systems. In 2008, Mindray was recognized as China's largest medical device manufacturer.[3]
Mindray was founded in 1991 inShenzhen, Guangdong[4] by seven former employees of Anke (安科), includingLi Xiting (李西廷),Xu Hang (徐航) and Cheng Minghe (成明和).[5] It grew by providing domestic patient monitoring, imaging, and other diagnostic products. Mindray maintains 41 subsidiaries and branch offices in 31 countries, as well as 32 branch offices in China. Mindray was listed on theNYSE in September 2006 and delisted in March 2016 to apply for a re-listing in China'sA-Share market.[6] Mindray was re-listed in theShenzhen Stock Exchange in October 2018.[7]
Mindray faced hiring controversy at the end of 2018 when it rescinded job offers from 254 university students due to changing economic conditions.[8] The company reinstated the offers in early 2019 citing 'corporate social responsibility' after public outcry.[9]
Mindray partnered with Korle Bu Teaching Hospital in January 2019 to improve diagnostic patient care inGhana. The company donated a SAL 6000 analyzer to improve local lab test efficiency.[10]
ThePatient Monitoring & Life Support division develops and manufactures multi-parameter patient monitors,biotelemetry systems,anesthesia delivery systems,defibrillators, ECG machines, pulse oxymeters, hospital beds, mounting systems and IT solutions.[11] In 2008, Mindray purchased the Patient Monitoring division of Datascope Corporation for $209 million to expand their presence outside of China.
TheIn-Vitro Diagnostic division provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment. This segment offers a range of semi-automated and fully automated diagnostic laboratory instruments for laboratories, clinics, and hospitals. Its products include hematology analyzers, biochemistry analyzers, reagents, a microplate reader and a microplate washer.
